
The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

